An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C

NCT01447446 · clinicaltrials.gov ↗

COMPLETED

Status

4442

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Peg-IFN Alfa-2a
DRUG: Peg-IFN Alfa-2b
DRUG: Ribavirin
DRUG: Boceprevir
DRUG: Telaprevir

Sponsor

Hoffmann-La Roche